XML 38 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
 6 Months Ended
Mar. 29, 2014
Mar. 30, 2013
Operating activities:    
Net earnings $ 25,947,000 $ 22,886,000
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation of fixed assets 15,591,000 13,864,000
Amortization of intangibles and deferred costs 2,511,000 2,388,000
Share-based compensation 1,049,000 916,000
Deferred income taxes (189,000) (86,000)
Loss on sale of marketable securities 296,000  
Other (126,000) (63,000)
Changes in assets and liabilities net of effects from purchase of companies    
Decrease(increase)in accounts receivable 636,000 (2,797,000)
Increase in inventories (5,106,000) (5,090,000)
Increase in prepaid expenses (633,000) (920,000)
Decrease in accounts payable and accrued liabilities (889,000) (2,543,000)
Net cash provided by operating activities 39,087,000 28,555,000
Investing activities:    
Payment for purchases of of companies, net of cash acquired (11,000,000)  
Purchases of property, plant and equipment (20,825,000) (15,557,000)
Purchases of marketable securities (25,747,000) (83,342,000)
Proceeds from redemption and sales of marketable securities 6,060,000 23,478,000
Proceeds from disposal of property and equipment 815,000 493,000
Other (92,000) (36,000)
Net cash used in investing activities (50,789,000) (74,964,000)
Financing activities:    
Payments to repurchase common stock   (2,763,000)
Proceeds from issuance of stock 1,023,000 2,576,000
Payments on capitalized lease obligations (204,000) (177,000)
Payment of cash dividend (8,966,000) (5,449,000)
Net cash used in financing activities (8,147,000) (5,813,000)
Effect of exchange rate on cash and cash equivalents (195,000) 362,000
Net decrease in cash and cash equivalents (20,044,000) (51,860,000)
Cash and cash equivalents at beginning of period 97,345,000 154,198,000
Cash and cash equivalents at end of period $ 77,301,000 $ 102,338,000